×

Global Human Albumin Industry Report 2014

Dublin, Nov. 20, 2014 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/k8c8c4/global_human) has announced the addition of the "Global Human Albumin Industry Report 2014" report to their offering.

The Global Human Albumin Industry Report 2014 is a professional and in-depth study on the current state of the global human albumin industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The human albumin market analysis is provided for the international markets including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets.

Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Human albumin industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided.

The report focuses on sixteen industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The human albumin industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 193 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


Key Topics Covered:

1. Executive Summary

2. India's Domestic Coal Market

  • Coal's Contribution in Fueling Indian Economy
  • Industry-wise Coal Quality and Quantity Requirements in India
  • Domestic Coal Legal Landscape and Supply Chain

3. Imported Coal Market in India - Current Scenario

  • Data Analysis of Coking Coal Imports
  • Data Analysis of Steam Coal Imports
  • Imported Coal Legal Landscape and Supply Chain

4. India Coal Demand Supply Analysis 2004

5. India Coal Demand Supply Analysis 2014

  • Future Domestic Coal Demand Supply
  • Future Imported Coal Demand Supply
  • Medium-run Scenario 2014-2
  • Long-run Scenario 2019-2
  • Future Market Value Assessment
  • Analysis of the Future Imported Coal Market - Overview

6. Deal Analysis of India's Overseas Asset Acquisitions

  • Analysis of Past Deals of Asset Acquisition
  • Key Drivers of the Deal

7. International Coal Quality Analysis & Benchmarking

  • International Coal Market
  • International Coal Quality Benchmarking

8. International Coal Price Analysis

  • International FOB Price Trends and Analysis

9. Quality Adjusted Prices of Indian and International Coal

10. Indian Coal - Demand Side Investment Analysis

  • Investments In Thermal Power Generation
  • Investments In Steel Production
  • Investments in Cement Production

11. Analysis of Investments in Supply Side (International Assets)

  • List of Prospective Assets in Six Major Countries
  • List of Major Suppliers in Six Major Countries
  • Assessment of Future Supply in Six Major Countries
  • Analysis of Legal and Regulatory Risks in Six Major Countries
  • Benchmarking Six Major Countries
  • Other Prospective Destinations

12. Strategies to Tap Opportunities

  • Strategies adopted by Indian Players in Acquiring Assets and Imports
  • Emerging Trends in Coal Imports and Trade
  • Global Coal Imports - Risk Analysis
  • Strategies for Future - Expert Opinion

13. Concluding Summary

14. Appendix


Companies Mentioned:

  • Baxter
  • Beijing Tiantan Biological Products Co.,Ltd (600161)
  • Biotest
  • China National Biotec Group
  • CSL
  • Grifols
  • Guangdong Shuanglin
  • Hualan Biological (002007)
  • Jiangxi Boya Biopharmaceutical Co.,Ltd
  • Octphama
  • Shanghai RAAS
  • Shanxi Kangbao Biological
  • Shenzhen Weiwuguangming
  • Tonrol Biopharmaceutical
  • Wuhan Institute of Biological Products Co.,Ltd
  • Yuanda Shuyang Pharmaceutical


For more information visit http://www.researchandmarkets.com/research/k8c8c4/global_human

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Healthcare and Medical Devices

Source:Research and Markets

More From Press Releases